Showing results (1611-1620 of 1,630) with videos related to

Sort By:
Pageof 163
Ecological Modelling|October 22, 2021
The Chesapeake Bay Program Modeling System: Overview and Recommendations for Future DevelopmentRaleigh R Hood, Gary W Shenk, Rachel L Dixon, et al.
Pulmonology|February 16, 2023
Alpha1-antitrypsin deficiency in Greece: Focus on rare variantsS A Papiris, M Veith, A I Papaioannou, et al.
Emerging Infectious Diseases|June 28, 2026
Inconsistent Strategies to Mitigate the Effects of Batrachochytrium salamandrivorans, EuropePhilipp Böning, Stefan Lötters, Vojtech Baláž, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|November 8, 2016
Versailles Project on Advanced Materials and Standards Interlaboratory Study on Measuring the Thickness and Chemistry of Nanoparticle Coatings Using XPS and LEISNatalie A Belsey, David J H Cant, Caterina Minelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 20, 2024
Biallelic ZBTB11 Variants: A Neurodevelopmental Condition with Progressive Complex Movement DisordersJuan Darío Ortigoza-Escobar, Mina Zamani, Nathalie Dorison, et al.
The Lancet. Infectious Diseases|May 19, 2020
Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case seriesMerle M Böhmer, Udo Buchholz, Victor M Corman, et al.
EMBO Molecular Medicine|March 7, 2022
Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromesSophia Grotz, Jessica Schäfer, Kirsten A Wunderlich, et al.
Nature Metabolism|July 23, 2020
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Nature Metabolism|July 23, 2020
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Progress in Cardiovascular Diseases|May 23, 2022
Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery diseaseKosmas I Paraskevas, Peter Gloviczki, Pier Luigi Antignani, et al.
Pageof 163